Abstract The goal of this study is to define the effects of TCF4 hemizygosity in the context of a larger segmental deletion of chromosome 18q. Our cohort included 37 individuals with deletions of 18q. Twenty-seven had deletions including TCF4 (TCF4
Introduction
It has recently been shown that hemizygosity of the TCF4 gene causes Pitt-Hopkins syndrome (MIM ID #610042) through a haploinsufficiency mechanism (Zweier et al. 2007) . The TCF4 gene is located at 18q21.1 and is, therefore, also hemizygous in some individuals with larger segmental deletions of 18q. The goal of this study is to define the effect of TCF4 hemizygosity in individuals with 18q deletions.
The constellation of phenotypic features known as Pitt-Hopkins syndrome is characterized by severe intellectual disability, wide mouth with fleshy lips, a beaked nose, and intermittent hyperventilation followed by apnea (Pitt and Hopkins 1978) . Since it was first described, the phenotype has been shown to have three different genetic causes. It can be caused dominantly by hemizygosity of or inactivating mutations in the TCF4 gene, or recessively by mutations in the CNTNAP2 gene on chromosome 7q35 or the NRXN1 gene on chromosome 2p16.3 (Zweier et al. 2009 ). Because this phenotype has multiple underlying molecular mechanisms, the phrase ''Pitt-Hopkins'' refers only to the clinically-defined syndrome.
The identification of the genetic bases of Pitt-Hopkins has allowed a fuller appreciation of the range of phenotypic features associated with mutations or deletions of these genes. It has recently been realized that 2% of individuals with phenotypic Angelman syndrome actually had TCF4 aberrations (Takano et al. 2010 ). In addition, Rosenfeld et al. (2009) identified seven cases with TCF4 deletions which were referred for chromosomal microarray analysis due to intellectual disability. In this genotypically ascertained group, a reevaluation of the phenotypic effects of TCF4 hemizygosity was undertaken. Of these patients, only 3 of 7 had a breathing abnormality and none had seizures, indicating that the penetrance of these features is significantly less than 100%. In their review of published cases likely caused by haploinsufficiency of TCF4 (N = 36), they found that the Pitt-Hopkins facial appearance was present in 91% of cases. Other features seen in more than half of the subjects included: severe psychomotor delay (97%), hypotonia (88%), happy disposition (85%) (though no elaboration of this behavior was provided), single palmar crease (69%), microcephaly (64%), constipation (58%), and brain abnormalities (56%).
Interestingly, variations in all three genes responsible for Pitt-Hopkins syndrome are associated with schizophrenia and autism. Hemizygous deletions of NRXN1 and CNTNAP2 as well as SNPs in both genes are associated with an increased risk of schizophrenia, epilepsy, and autism spectrum disorder (Kirov et al. 2009; Friedman et al. 2008) and SNPs of TCF4 have been associated with a slightly increased risk of schizophrenia (Stefansson et al. 2009 ). In addition, individuals with 18q deletions including TCF4, NETO1 and FBXO15 are more likely to exhibit autistic-like behavior (O'Donnell et al. 2010) . These data point to a potential functional relationship between the products of these three genes as well as a causal relationship between autism and schizophrenia.
The TCF4 gene produces a basic helix-loop-helix (bHLH) transcription factor which acts through binding to E-box consensus sequences in the promoter regions of the target genes. It belongs to a family of proneural bHLH transcription factors controlling differentiation of neuronal subtypes. The temporal and spatial differentiation of the numerous neural cell types is controlled by a relatively small number of transcription factors acting as homo-and hetero-dimers. The hetero-dimerization of transcription factors produces a greater diversity of regulatory combinations, thereby a greater diversity and specificity of gene expression (Guillemot 2007) . It is likely that the TCF4 gene product interacts with numerous other transcription factors. In the mouse, Tcf4 dimerizes with Math1, another bHLH transcription factor. Interestingly, mice hemizygous for Math1 die shortly after birth from central apnea (Rose et al. 2009 ).
One of the overall goals of our research group is to determine which genes on 18q contribute to the 18q-phenotype through haploinsufficiency. This information will eventually allow the molecular karyotype to be predictive with regard to the phenotype. The aim of this study was to determine the extent to which hemizygosity of TCF4 contributes to the physical and behavioral phenotype in people with segmental 18q deletions.
Methods

Subject recruitment
Potential participant families learn about the research study from a variety of sources. Primarily, however, families are referred to the Research Center from the Chromosome 18 Registry & Research Society. Eligibility for the study requires a cytogenetic or molecular diagnosis of an 18q deletion. This study was approved by the Institutional Review Board of the University of Texas Health Science Center at San Antonio. All families were and continue to be involved in the informed consent process, which is appropriately documented.
Phenotypic assessment
For all families enrolling at the Chromosome 18 Clinical Research Center, phenotypic data are compiled from three sources. First, upon enrollment, families provide the Research Center with extensive medical records to document the participant's medical and developmental histories. These data are entered into a relational database which is updated annually with the most recent medical and developmental information obtained from the families, providing longitudinal data on each of the study participants. Second, all families are solicited annually by mail to complete psychological surveys. Parents are asked to complete the following questionnaires and return them by mail: Behavior Assessment System for Children-Second Edition (BASC-2; Reynolds and Kamphaus 2004) which provides information regarding the presence of behavior problems and emotional disturbance; the Vineland Adaptive Behavior Scales-Second Edition (Sparrow et al. 2005) which asks parents to rate communication, daily living and socialization skills and the Gilliam Autism Rating Scale-First Edition (GARS; Gilliam 1995) or Second Edition (GARS-2; Gilliam 2006) which provides an overall probability of autism rating.
The third data source is the comprehensive clinical evaluation at the Chromosome 18 Clinical Research Center as previously described ).
The evaluation completed at the Research Center includes a comprehensive neuropsychological evaluation comprised multiple measures. To obtain a measurement of estimated cognitive functioning, an individually administered measure of ability is given. If the participant is able to understand the task demands to the extent that it is possible to obtain a reliable and valid estimate of ability, then measures based on the chronological age are given: Bayley Scales of Infant and Toddler Development-Third Edition (Bayley 2006) ; Differential Abilities Scales-Second Edition (Elliot 2007) or the Wechsler Adult Intelligence Scales-Third Edition (Wechsler 1997 ). If it is not possible to evaluate the intellectual functioning using tasks and activities based on their chronological age, it is necessary to employ standardized measures which are routinely used to assess the cognition, language, and motor abilities of infants and toddlers. Because some participants are significantly older than the normative comparison group for these evaluations no standard comparison was possible. Therefore, estimates of cognitive functioning are generated from age equivalent scores.
To gain additional information about the group of participants described in this project, it was necessary to re-contact participating families to fill in gaps in the data and to address new questions. All families participating in this study were contacted by telephone to obtain additional information about the participant's respiratory history, including abnormal breathing patterns.
Genotypic assessment
The DNA of all participants was evaluated using custom designed oligonucleotide microarray comparative genomic hybridization as previously described ). All participants in the study cohort assessed here had a hemizygous region of 18q without other major chromosomal copy number changes.
Results
To determine the contribution of TCF4 hemizygosity to the overall phenotype of 18q-, we compared the phenotypes of those with and without hemizygosity of TCF4. We have a cohort of over 200 individuals with hemizygosity for a portion of chromosome 18q, each with a unique hemizygous region ). Within this cohort, there are 27 individuals with a deletion that includes TCF4 (TCF4 ?/-). As shown in Fig Within our cohort, there are 132 individuals with terminal deletions of 18q with breakpoints distal to the TCF4 gene (TCF4 ?/? ). The comparison group was selected from these individuals. We selected the TCF4
?/? individuals with the specific aim of creating a comparison group of similar size to the TCF4 ?/-group. Because we had cognitive data on 8 of the TCF4
?/-individuals and adaptive behavior data on 11, we selected nine TCF4
?/? individuals with breakpoints as close as possible to TCF4 to serve as a control group. Parenthetically, the next smallest deletion contained several more genes than other members of the control group. The photographs of six of these individuals are shown in Fig. 2n -s.
In this study, the TCF4 ?/? and TCF4 ?/-groups were compared with regard to both physical and behavioral phenotypes. The TCF4
?/-group included 27 individuals: 12 males and 15 females. Since this is a longitudinal study, the information was gathered over a period of time. However, the age range at the most recent assessment was 10 months to 24 years 7 months, with an average age of 10 years 10 months. The TCF4
?/? group of nine individuals included four males and five females with an average age range from 10 months to 28 years 7 months with an average age of 13 years.
We aimed to (1) identify which features are found only in the TCF4
?/-group, and (2) determine the incidence of features associated with the Pitt-Hopkins phenotype in both the TCF4
?/-group and the TCF4 ?/? group. The physical features that distinguish the TCF4 ?/-group from the TCF4 ?/? group are listed in Table 1 (Zweier et al. 2007 (Zweier et al. , 2008 Pitt and Hopkins 1978; Rosenfeld et al. 2009; Amiel et al. 2007; Andrieux et al. 2008; Brockschmidt et al. 2007; de Pontual et al. 2009; Giurgea et al. 2008; Kalscheuer et al. 2008; Peippo et al. 2006; Singh 1993; Van Balkom et al. 1998) . Only abnormalities of the corpus callosum (64%) were found in more than half of the TCF4 ?/-group. Other features were found in fewer than 35% of participants with TCF4 hemizygosity, yet were unique to this group.
We then compared the non-unique phenotypic features between the two groups. The features previously described as associated with Pitt-Hopkins syndrome are indicated in italics (Rosenfeld et al. 2009 ). These findings are shown in Table 2 and reveal that the majority are non-specific findings often associated with many different conditions (Zweier et al. 2007 (Zweier et al. , 2008 Pitt and Hopkins 1978; Rosenfeld et al; Amiel et al. 2007; Andrieux et al. 2008; Brockschmidt et al. 2007; de Pontual et al. 2009; Giurgea et al. 2008; Kalscheuer et al. 2008; Peippo et al. 2006; Singh 1993; Van Balkom et al. 1998; Taddeucci et al. 2010 ).
Hum Genet (2011) 130:777-787 779 To isolate the effect of TCF4 hemizygosity on cognitive functioning, we wanted to compare the TCF4 ?/-group with terminal deletions (N = 13) to the control group of nine TCF4
?/? individuals who also had terminal deletions. However, we had cognitive data from in-person assessments on only 8 of the 13 individuals in the TCF4 ?/-group. Table 3 presents the estimated intellectual abilities of these two groups by age. As Table 3 indicates, the estimated intellectual abilities for the TCF4
?/? group range from mild intellectual disability to low average cognitive functioning. This is quite mild in comparison to the eight persons in the TCF4
?/-group. In this group, cognitive and motor development is very significantly delayed with standard scores within the profound to severe range of intellectual disability. In fact, the individuals in the TCF4 ?/-group were unable to do even the easiest items of each intellectual assessment instrument designed to assess typical children under 1 year of age. Therefore, the most informative indication of their cognitive function was to report their age equivalent; the age at which the skills are acquired in a typically developing child. These pronounced deficits were present in children under 5 years of age and continue to be present across the lifespan into child and young adulthood. In general, the cognitive and motor growth pattern is essentially flat across the lifespan meaning that they did not acquire additional skills beyond that of a 12 months old.
We also compared the language development of these same two groups of individuals. All persons in the TCF4
?/-group are nonverbal with receptive language limited to reactions to sounds in the environment, calming when spoken to and recognition of caregiver's voice with ?/? group, six of the nine persons communicate verbally; one child uses sign language to communicate; and two individuals were under the age of two at the time of testing and were not yet speaking. These two toddlers do however communicate through the use of engaged eye contact, facial expressions, gestures and subvocalizations.
Parents in both terminal deletion groups completed an adaptive behavior questionnaire which compared the communication, daily living, and socialization skill development of their children with a normative group of same-age peers. We had data on 11 of the 13 individuals in the terminal deletion TCF4
?/-group using this instrument (Table 4) . Parental ratings of both groups across all domains were congruent with the intellectual assessment results obtained through one-on-one assessment. The adaptive behavior functioning of the TCF4 ?/-group was rated as severely impaired while the behavioral functioning of the TCF4 ?/? group was rated as falling within the mild range of impairment.
Parents also completed the BASC-2 which provides an evaluation of problem behaviors which fall into three general areas: externalizing problems (hyperactivity, aggressiveness, conduct problems); internalizing problems (anxiety, depression, somatization) and those in the behavior index [atypicality (disconnection from reality), withdrawal and attention problems]. Only problems with attention were rated by parents in both groups as cause for concern (average T-Score = 63.18 for the TCF4 ?/-group and average T-Score = 60.55 for the TCF4 ?/? group). Average parental ratings across all of the other domains were within normal or typical limits compared with same age peers.
To determine the presence of behaviors consistent with autism, parents evaluated their children's communication and social skill functioning along with the presence of stereotyped or perseverative behaviors using one of the Gilliam Autism Rating Scales (GARS or GARS-2). The Individuals with terminal deletions and breakpoints closest to but not including TCF4. n 25 years 9 months, o 14 years, p 7 years 5 months, q 8 years 9 months, r 6 years 6 months, s 1 year 2 months. One individual with a small interstitial deletion that includes only the TCF4 gene. t 12 years 8 months Hum Genet (2011) 130:777-787 781 GARS is a screening tool and should not be used alone to make a definitive diagnosis of autism. Therefore, scores from this instrument are cataloged as to the probability of having an autistic diagnosis. Parental ratings of children in the TCF4 ?/-group indicated a very likely or high probability of autism being part of the diagnostic picture while the ratings of parents of children in the TCF4
?/? group indicated that it was a possibility.
Within the group of TCF4 ?/-, children who had been evaluated at the Research Center, there is great genotypic variability between the individuals with regard to the number of other genes involved in the deletion. Although the behavioral and cognitive data presented in Tables 3 and  4 are from only those individuals with terminal deletions, we wished to evaluate whether other regions of hemizygosity of 18q had an impact on the effect of TCF4 hemizygosity. For this analysis, we now included the cognitive data from both the interstitial as well as the terminal deletions in the TCF4 ?/-group. Again, these data were not available on every individual whose genotype data are shown in Fig. 1 and phenotype data shown in Tables 1 and  2 . Because there are no other genes on 18q specifically identified as haploinsufficient, the comparison between the TCF4 ?/-subgroups was made based on grouping them by the size of their deletion. We created three sub-groups: those with terminal deletions (N = 13, 8 with cognitive data), those with large interstitial deletions (N = 8, 5 with cognitive data) and those with small interstitial deletions (N = 6, 4 with cognitive data). The behavioral performance of these three groups was compared to each other. In addition, we have one participant, age 12 years and 8 months who has a small interstitial deletion of only the TCF4 gene whose data have not been included elsewhere in our analysis. Again, age equivalent scores were generated for the three groups because the use of standard peerbased assessment measures was not possible due to the participants' very low cognitive and motor functioning. As Table 5 indicates, the cognitive functioning of the three groups is not significantly different. All three groups of people hemizygous for the TCF4 gene have significantly delayed cognitive and motor functioning. This suggests that the size of the hemizygous region has little to no effect on the developmental impact of the TCF4 gene. In essence, the effect of TCF4 hemizygosity is so profound that, with regard to development, children with large regions of hemizygosity including many other genes are not more developmentally delayed than children with hemizygosity for the TCF4 gene alone.
One of the more striking findings was the realization that, within our large cohort of people with simple terminal 18q deletions (N = 132), the majority of individuals who died before the age of 18 had a deletion that included the TCF4 gene. Figure 3 illustrates this point. The figure shows either the current age or the age of death for the two Cognitive abilities AE = 1.3 months of age AE = 7 months of age AE = 6 months of age Motor abilities AE = 2 months of age AE = 6 months of age AE = 6 months of age CA chronological age, AE age equivalent a Average standard scores with a mean of 100 and a standard deviation of 15 subgroups within our entire cohort; those with one copy of TCF4 and those with two copies of TCF4. We investigated the cause of death by reviewing medical records and interviewing the parents. While a variety of reasons were given for the cause of death, almost all of the children who died had a history of multiple pneumonias, primarily thought to be due to chronic aspiration, as is common in such severely delayed children. This may have been complicated by the breathing abnormalities that are common in the affected individuals.
Discussion
The analysis revealed three key observations. First, the features unique to those with TCF4 hemizygosity were abnormal corpus callosum, small penis, accessory nipples, broad or clubbed fingers, sacral dimple, short neck and wide spaced nipples. The potentially most clinically significant of these physical findings is an abnormally thin or absent corpus callosum. It would be reasonable to expect that such an abnormality would be associated with an inability to walk. However, none of the individuals with TCF4 hemizygosity in our cohort were able to walk regardless of the morphology of their corpus callosum. This should not imply that all individuals with TCF4 deletions are never able to walk. There is anecdotal evidence that some children with TCF4 are able to walk; however, none of the individuals enrolled in this study had attained that milestone. Second, it could be anticipated that individuals with larger deletions that include TCF4 might be more impaired physically and mentally than those with smaller deletions. However, we did not find this to be true. The presence or absence of TCF4 seems to be more important in predicting severity than the size of the deletion. We are fortunate to have in this sample an individual with TCF4 hemizygosity alone. As Table 5 illustrates, this person has significant cognitive and motor delay. Given the very small number of persons in each of our three sub-groups missing the TCF4 gene, it is not possible to determine if the differences in age equivalent scores among these three deletion types are statistically significant. Functionally, however, the cognitive and motor delays across all groups are significant and appear to be lifelong. In fact, in the cohort we evaluated, TCF4 hemizygosity resulted in a developmental ceiling of 12 months irrespective of chronologic age, which ranged from 10 to 238 months.
Third, the analysis of the ages and the age at death of those with TCF4 hemizygosity and those with deletions of chromosome 18 not including the TCF4 gene showed that TCF4 hemizygosity conferred an increased risk of early death. The cause of death was in most cases related to the consequences of chronic aspiration.
The long-term goal of the Research Center is to determine which genes are responsible for which aspects of the phenotype of 18q-. In this study, we analyzed the effect of TCF4 hemizygosity to determine which components of the ; data from 132 individuals with simple distal 18q deletions. Average current age of those with two copies of TCF4 is 17 years. The two individuals in this group who died were a female age 20 years, 6 months and a male 19 years, 9 months. TCF4
?/-data from 22 subjects average current age is 11.5 years. Average age at death was 12 years old. The five participants who died included two males and three females; ages 22 months, 6 years 10 months, 13 years, 20 years 11 months, and 22 years 18q-phenotype can be attributed to the loss of one copy of the gene. We compared the TCF4
?/-group with the TCF4 ?/? group using data from medical records, parental questionnaires and in-person physical and behavioral evaluations. Comparison to the literature was somewhat hampered by the dearth of detailed phenotypic information in previously reported cases of Pitt-Hopkins. Much of the syndrome description is limited to dysmorphology, much of which is imprecise, (e.g., ''microcephaly''), and medical record abstraction. In particular, the behavioral and developmental assessments are very limited in scope. This made comparisons to the literature difficult. There is an urgent need, now that the molecular genetics are known, to perform a comprehensive multidisciplinary assessment of a cohort of individuals with hemizygosity of or loss of functions mutations in the TCF4 gene alone.
It is interesting to note that, in our population, the only Pitt-Hopkins phenotypic components that were unique to those with TCF4 hemizygosity were thin or absent corpus callosum, small penis, accessory nipples, broad or clubbed fingers, sacral dimple, short neck and wide spaced nipples. Results of our analysis indicated that many of the features of Pitt-Hopkins were present in both the TCF4
?/-as well as the TCF4 ?/? populations. Two of the reported cardinal features of Pitt-Hopkins syndrome are irregular breathing and seizures. The breathing abnormality phenotype is poorly documented in the literature, so we were not able to distinguish between documented central apnea, episodes of heavy breathing and hyperventilation. Interestingly, in our population this feature was not unique to those with TCF4 hemizygosity. Likewise, seizures were not unique to the TCF4 ?/-group. This is in part due to the fact that many of the features such as hypotonia, single palmar crease, microcephaly, and seizures are genetically heterogeneous and therefore non-specific findings.
Alterations in the TCF4 gene have been implicated in schizophrenia, and schizophrenia associated genes have been linked to myelin-related pathways (Rietkerk et al. 2009 ). Since a key gene important in the compaction and function of myelin (MBP) is located near the end of 18q, and individuals with deletions of a critical region that includes this gene have dysmyelination of the brain ), it might be postulated that hemizygosity of both TCF4 and MBP would exacerbate their individual effects. However, we did not see significant differences between the TCF4 hemizygous participants whose 18q deletion included the myelin basic protein gene (MBP) (terminal deletions) and those that did not (interstitial deletions) as shown in Table 5 .
These data help us to make recommendations for this unique group of individuals with 18q deletions. The cause of death data highlights the need for aggressive detection and intervention to prevent aspiration. Our data also highlight the deleterious and chronic impact that hemizygosity of the TCF4 gene has on cognitive and behavioral development. In our study, all individuals hemizygous for the TCF4 gene regardless of their age were similar to typically developing babies less than 12 months old. It is critical that parents plan for the long-term 24-h care their children will need and refocus their developmental expectations. It is important to provide a nurturing environment that is rich in sensory stimulation and is one where the child can feel comfortable and secure.
Of note, we are now faced with the challenge of devising a meaningful nomenclature for 18q-that conveys both the information about the genotype and as well as its implications for phenotype. In this study, we used the mouse nomenclature as a guide, since our goal is to merely indicate gene copy number. We are indicating the diploid state with regard to the TCF4 gene as TCF4
?/? and the hemizygous state as TCF4
?/-. However, as we are able to classify more genes as being either haplosufficient or haploinsufficient, it will become a challenge for the molecular cytogeneticist to write a clinically meaningful karyotype. We do not envision a diagnostic code for someone with a segmental deletion to include a long list of all the hemizygous genes, but rather an edited list of those genes that are haploinsufficient, i.e. have clinical significance. Ultimately such a genotype would imply a particular phenotype and thereby direct a plan of medical surveillance and therapy.
Lastly, these data reinforce the need to eliminate the word ''syndrome'' when referring to 18q-for two reasons. First, rather than being defined by a constellation of features, this condition is defined by a genotype, as implied by the fact that it is named after the type of chromosome aberration. Second, this particular chromosome abnormality is uniquely heterogeneous. No two unrelated individuals have the same exact region of hemizygosity. Therefore, we could identify numerous pairs of individuals who both have 18q-yet have no hemizygous genes in common ). The term ''syndrome'', which implies a collection of similar phenotypic findings attributable to the same genetic cause, is thus not appropriate. Rather, the data presented here begin to define the molecular basis of 18q-, highlighting the role of genomic heterogeneity in creating phenotypic heterogeneity. Thus, the word ''syndrome'' is no longer appropriate.
